LATEST NEWS
Tumor Mutation Burden Study Shows Viability of In-House Testing
As laboratories increasingly look to bring advanced molecular testing in-house, the results of a new retrospective clinical research study show that tumor mutation burden...
Read More
Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360
Guardant Health, Inc. (Nasdaq: GH), announced that its market leading liquid biopsy, Guardant360®, will be a covered benefit for the members of the health...
Read More
SomaLogic announces new collaboration with Janssen Research & Development
SomaLogic, Inc. has announced that it has entered into a collaborative agreement with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies...
Read More
FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia
The FH Foundation recently announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal...
Read More
SOPHiA GENETICS Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection
SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight...
Read More
PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive Health Management
Today, in collaboration with Helix, PerkinElmer, Inc., a global leader committed to innovating for a healthier world, launched GenePrism: Actionable Insights, a new genetic...
Read More
Only 36 hours left to register for PMLS EAST in Philadelphia - make sure you are part of the conversation with lead…